BRIEF

on Fresenius SE & Co. KGaA (ETR:FRE)

Fresenius Expands Strategic Partnership with SAP through Investment in Avelios Medical

Stock price chart of Fresenius SE & Co. KGaA (EBR:FRE) showing fluctuations.

Fresenius has announced an investment in Avelios Medical, a company developing a next-generation hospital information system. This move enhances the strategic partnership with SAP, aiming to create a digital healthcare ecosystem for Europe. The goal is to combine clinical expertise and technological capabilities to develop an AI-enabled infrastructure for hospitals.

Avelios Medical's solution offers a modular system for digitalizing clinical and administrative processes. It supports data sovereignty and AI integration, providing a scalable platform that aids care teams and accelerates innovation in clinical practice.

Christian Pawlu, COO of Fresenius Helios, emphasizes the importance of combining medical excellence and technology. Avelios, led by CEO Christian Albrecht, views this partnership as pivotal for an open, AI-native health platform.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Fresenius SE & Co. KGaA news